Michael Chambers

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Michael Chambers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Chambers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Director Common Stock 284K $28.4M $100.13 Mar 10, 2025 By Revocable Trust
Sarepta Therapeutics, Inc. Director Common Stock 10.7K $1.07M $100.13 Mar 10, 2025 Direct
Sarepta Therapeutics, Inc. Director Stock Options (right to buy) 4.79K Mar 10, 2025 Direct

Insider Reports Filed by Michael Chambers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRPT Sarepta Therapeutics, Inc. Mar 10, 2025 2 $0 4 Mar 11, 2025 Director
SRPT Sarepta Therapeutics, Inc. Aug 16, 2024 3 $4.96M 4 Aug 20, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Director
SRPT Sarepta Therapeutics, Inc. Aug 14, 2023 2 $1.09M 4 Aug 15, 2023 Director
SRPT Sarepta Therapeutics, Inc. Aug 11, 2023 1 $2.56M 4 Aug 14, 2023 Director
SRPT Sarepta Therapeutics, Inc. Aug 10, 2023 3 $3.7M 4 Aug 11, 2023 Director
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
SRPT Sarepta Therapeutics, Inc. Sep 14, 2022 3 $5.96M 4 Sep 15, 2022 Director
SRPT Sarepta Therapeutics, Inc. Sep 13, 2022 1 $20M 4 Sep 14, 2022 Director
SRPT Sarepta Therapeutics, Inc. Aug 19, 2022 2 $5M 4 Aug 22, 2022 Director
SRPT Sarepta Therapeutics, Inc. Jun 2, 2022 2 $0 4 Jun 6, 2022 Director
SRPT Sarepta Therapeutics, Inc. Jun 2, 2022 0 $0 3 Jun 6, 2022 Director